Stay updated on High Dose Cytarabine + Pembrolizumab in AML Clinical Trial
Sign up to get notified when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.

Latest updates to the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows a recruitment status, and adds guidance sections for reading the study record and joining the study. The Interventions/Treatment label is reformatted and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check20 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing Revision: v3.5.4, indicating a minor version update to the page's documentation/markup rather than substantive study information.SummaryDifference0.1%

- Check41 days agoChange DetectedNew revision tag v3.5.4 was added, replacing the previous v3.5.3. This reflects an update to the page’s release/version labeling rather than substantive content changes.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page revision marker was updated from v3.5.0 to v3.5.3, reflecting a maintenance/version update rather than a change to any clinical trial information.SummaryDifference0.1%

- Check99 days agoChange DetectedThe website revision label was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check113 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No other visible content changes were detected.SummaryDifference0.1%

Stay in the know with updates to High Dose Cytarabine + Pembrolizumab in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.